Results 171 to 180 of about 10,670 (219)
Some of the next articles are maybe not open access.
Boron neutron capture therapy for glioblastoma
Cancer Letters, 2008Boron neutron capture therapy (BNCT) theoretically allows the preferential destruction of tumor cells while sparing the normal tissue, even if the cells have microscopically spread to the surrounding normal brain. The tumor cell-selective irradiation used in this method is dependent on the nuclear reaction between the stable isotope of boron ((10)B ...
Tetsuya, Yamamoto +2 more
openaire +2 more sources
Boronated Thymidine Analogues for Boron Neutron Capture Therapy
Nucleosides, Nucleotides and Nucleic Acids, 2006Concise synthetic methods for synthesizing 3-carboranyl thymidine analogues (3CTAs) modified with cyclic and acyclic alcohols have been developed. The synthesis of these potential boron neutron capture therapy (BNCT) agents and their preliminary biological evaluation is described.
B T S, Thirumamagal +9 more
openaire +2 more sources
Boron neutron capture therapy.
The British Journal of Radiology, 1997mal or epithermal neutron irradiation. Naturallythe Petten High Flux Reactor Centre, Holland and occurring 10B has a very high affinity for thermal at the University of Helsinki, Finland. Other neutrons, having a thermal neutron cross-section European Centres, including the UK group in of 3838 barns for the 10B(n, a) 7Li reaction.
openaire +2 more sources
Ligand Liposomes and Boron Neutron Capture Therapy
Journal of Neuro-Oncology, 2003Boron neutron capture therapy (BNCT) has been used both experimentally and clinically for the treatment of gliomas and melanomas, with varying results. However, the therapeutic effects on micro-invasive tumor cells are not clear. The two drugs that have been used clinically, p-boronophenylalanine, (BPA), and the sulfhydryl borane, (BSH), seem to be ...
Jörgen, Carlsson +5 more
openaire +2 more sources
Fractionation in Boron Neutron Capture Therapy
1989The theoretical basis has been described for the value of BNCT in the treatment of cerebral glioblastoma multiforme.1 Early clinical trials in the United States showed unexpected and excessive damage to normal brain tissue. Subsequent analysis suggests that this damage was due to high levels of boron in blood at the time of irradiation.
K R, Durrant, J, Hopewell
openaire +2 more sources
Boron Compounds for Neutron Capture Therapy
1989There have been two main approaches to the development of boron compounds for neutron capture therapy (BNCT). One has involved the synthesis of boronated analogues of organic structures which possess a high degree of selectivity for neoplastic cells. These include amino acids, nucleic acid precusors, porphyrins and promazines.
F, Alam +4 more
openaire +2 more sources
Medical Physics, 1999
The potential efficacy of boron neutron capture therapy (BNCT) for malignant glioma is a significant function of epithermal‐neutron beam biophysical characteristics as well as boron compound biodistribution characteristics. Monte Carlo analyses were performed to evaluate the relative significance of these factors on theoretical tumor control using a ...
Wheeler, Floyd +8 more
openaire +2 more sources
The potential efficacy of boron neutron capture therapy (BNCT) for malignant glioma is a significant function of epithermal‐neutron beam biophysical characteristics as well as boron compound biodistribution characteristics. Monte Carlo analyses were performed to evaluate the relative significance of these factors on theoretical tumor control using a ...
Wheeler, Floyd +8 more
openaire +2 more sources
2001
Boron neutron capture therapy in Japan was started by H. Hatanaka at HTR in 1968. Successively, four reactors (HTR, MuITR, KUR, and JRR-2) were authorized for medical use (Figure 1). He modified the method developed by W. Sweet. Furthermore, he decided to introduce BSH, which was discovered and tested by his coworker A. H.
openaire +1 more source
Boron neutron capture therapy in Japan was started by H. Hatanaka at HTR in 1968. Successively, four reactors (HTR, MuITR, KUR, and JRR-2) were authorized for medical use (Figure 1). He modified the method developed by W. Sweet. Furthermore, he decided to introduce BSH, which was discovered and tested by his coworker A. H.
openaire +1 more source
Dose prescription in boron neutron capture therapy
International Journal of Radiation Oncology*Biology*Physics, 1994The purpose of this paper is to address some aspects of the many considerations that need to go into a dose prescription in boron neutron capture therapy (BNCT) for brain tumors; and to describe some methods to incorporate knowledge from animal studies and other experiments into the process of dose prescription.Previously, an algorithm to estimate the ...
N, Gupta +3 more
openaire +2 more sources
Glioblastoma: Boron Neutron Capture Therapy
2011Boron neutron capture therapy (BNCT) is a unique method that can deliver tumor-cell-selective high-linear energy transfer (LET) particle radiotherapy to an extended target area encompassing a microscopic invasion while avoiding radiation damage to the surrounding normal brain tissue.
Tetsuya Yamamoto +2 more
openaire +1 more source

